<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-11-21T02:18:32Z</responseDate><request verb="GetRecord" identifier="oai:macsphere.mcmaster.ca:11375/13312" metadataPrefix="dim">https://prod-ms-be.lib.mcmaster.ca/server/oai/request</request><GetRecord><record><header><identifier>oai:macsphere.mcmaster.ca:11375/13312</identifier><datestamp>2026-09-24T04:52:27Z</datestamp><setSpec>com_11375_271</setSpec><setSpec>col_11375_272</setSpec></header><metadata><dim:dim xmlns:dim="http://www.dspace.org/xmlns/dspace/dim" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:doc="http://www.lyncode.com/xoai" xsi:schemaLocation="http://www.dspace.org/xmlns/dspace/dim http://www.dspace.org/schema/dim.xsd">
   <dim:field mdschema="dc" element="contributor" qualifier="advisor" lang="en_US">Rosenthal, Kenneth L.</dim:field>
   <dim:field mdschema="dc" element="contributor" qualifier="advisor" lang="en_US">Stampfli, Martin</dim:field>
   <dim:field mdschema="dc" element="contributor" qualifier="author" lang="en_US">Henrick, Bethany M.</dim:field>
   <dim:field mdschema="dc" element="contributor" qualifier="department" lang="en_US">Medical Sciences</dim:field>
   <dim:field mdschema="dc" element="date" qualifier="accessioned">2014-06-18T17:03:36Z</dim:field>
   <dim:field mdschema="dc" element="date" qualifier="available">2014-06-18T17:03:36Z</dim:field>
   <dim:field mdschema="dc" element="date" qualifier="created" lang="en_US">2013-09-10</dim:field>
   <dim:field mdschema="dc" element="date" qualifier="issued" lang="en_US">2013-10</dim:field>
   <dim:field mdschema="dc" element="identifier" qualifier="other" lang="en_US">opendissertations/8130</dim:field>
   <dim:field mdschema="dc" element="identifier" qualifier="other" lang="en_US">9233</dim:field>
   <dim:field mdschema="dc" element="identifier" qualifier="other" lang="en_US">4569550</dim:field>
   <dim:field mdschema="dc" element="identifier" qualifier="uri">http://hdl.handle.net/11375/13312</dim:field>
   <dim:field mdschema="dc" element="identifier" qualifier="uri">https://doi.org/10.71548/8892</dim:field>
   <dim:field mdschema="dc" element="description" qualifier="abstract" lang="en_US">&lt;p>Breastfeeding from HIV-infected mothers is one of the major sources of pediatric HIV-1 infection; however, an intervention that promotes exclusive breastfeeding has significantly reduced vertical HIV transmission rates and infant mortality. The mechanisms underlying this phenomenon remain unknown; however, have been closely linked to high levels of innate immune factors in breast milk. Indeed, the level of several innate factors in breast milk correlate with protection and/or have direct anti-viral properties &lt;em>in vitro.&lt;/em> The innate immune factor, soluble TLR2 (sTLR2) is found in high concentration in breast milk and has previously been investigated for its anti-bacterial properties; however, its anti-viral properties remain poorly understood. Thus, the research presented in this thesis extended our understanding of sTLR2 by characterizing the mechanisms by which sTLR2 inhibited HIV-induced inflammation and infection. Chapter 2 examined the predominant forms of sTLR2 in breast milk from different women, its cellular source, bioavailability and kinetics postpartum. Functionally, we confirmed sTLR2’s anti-bacterial properties and extended to show, for the first time, that sTLR2 directly inhibited HIV infection &lt;em>in vitro.&lt;/em> Chapter 3 documented a potential mechanism of sTLR2’s direct inhibition of HIV infection &lt;em>in vitro&lt;/em> and, investigated sTLR2 and TLR2 expression in HIV uninfected compared to HIV infected breast milk and breast milk cells, respectively. Chapter 4 investigated the role of TLR2’s recognition of novel HIV pathogen associated molecular patterns (PAMPs), and whether TLR2 expression increased HIV infection and integration. Taken together, we present novel anti-viral functions of sTLR2 by demonstrating that sTLR2 bound to specific HIV PAMPs, which led to significantly decreased HIV-induced inflammation, co-receptor expression, and HIV infection. Furthermore, we demonstrated, for the first time, that TLR2 recognizes specific HIV PAMPs, which led to significantly increased pro-inflammatory cytokine production, co-receptor expression and HIV infection. Thus, sTLR2 and TLR2 represent innate immune factors that might have preventative and therapeutic applications for both infants and adults in the future.&lt;strong>&lt;br /> &lt;/strong>&lt;/p></dim:field>
   <dim:field mdschema="dc" element="description" qualifier="degree" lang="en_US">Doctor of Philosophy (Medical Science)</dim:field>
   <dim:field mdschema="dc" element="subject" lang="en_US">Innate immunity; innate factors; breast milk; mother-to-child transmission; Toll-like receptor 2 (TLR2); soluble Toll-like receptor 2 (sTLR2)</dim:field>
   <dim:field mdschema="dc" element="subject" lang="en_US">Medical Immunology</dim:field>
   <dim:field mdschema="dc" element="subject" lang="en_US">Virus Diseases</dim:field>
   <dim:field mdschema="dc" element="subject" lang="en_US">Medical Immunology</dim:field>
   <dim:field mdschema="dc" element="title" lang="en_US">CHARACTERIZING THE ROLE OF TOLL-LIKE RECEPTOR 2 IN SENSING AND REGULATING HUMAN IMMUNDEFICIENCY VIRUS-1 INFECTION FROM MOTHER-TO-CHILD THROUGH BREAST MILK</dim:field>
   <dim:field mdschema="dc" element="type" lang="en_US">thesis</dim:field>
   <dim:field mdschema="others" element="access-status">open.access</dim:field>
</dim:dim></metadata></record></GetRecord></OAI-PMH>